APTN Adaptin Bio, Inc.

Fundamentals / CIK 0001938571 / USD

Adaptin Bio, Inc. reported $1.09M in total assets and a net loss of $4.68M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open APTN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$0$0$0-$4.83MFY 2023 Net Income: -$86K2023FY 2024 Net Income: -$3.12M2024FY 2025 Net Income: -$5.17M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Research & Development $1.77M $1.82M --
Total Operating Expenses $5.41M $2.57M --
Operating Income -$5.41M -$2.57M -$86K
Interest Expense $73K $341K --
Income Before Tax -$5.17M -$3.12M --
Net Income -$5.17M -$3.12M -$86K
Basic EPS -$0.66 -$0.96 -$0.02
Diluted EPS -$0.66 -$0.96 -$0.02
Basic Shares Outstanding 7.8M 3.2M 5.0M
Diluted Shares Outstanding 7.8M 3.2M 5.0M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $116K $138K $166K $593K $779K $340K $62K $258K
Total Operating Expenses $954K $1.20M $1.14M $1.37M $1.68M $1.52M $850K $508K
Operating Income -$954K -$1.20M -$1.14M -$1.37M -$1.68M -$1.52M -$850K -$508K
Interest Expense $3.0K $4.7K $1.9K $0 $0 $0 $73K $146K
Income Before Tax -$957K -$1.21M -$1.15M -$1.37M -$1.68M -$1.52M -$603K -$857K
Net Income -$957K -$1.21M -$1.15M -$1.37M -$1.68M -$1.52M -$603K -$857K
Basic EPS -$0.10 -$0.14 -$0.13 -- -$0.20 -$0.18 -$0.10 --
Diluted EPS -$0.10 -$0.14 $0.13 -- -$0.20 -$0.18 $0.10 --
Basic Shares Outstanding 9.2M 8.8M 8.7M -- 8.5M 8.5M 5.8M --
Diluted Shares Outstanding 9.2M 8.8M 8.7M -- 8.5M 8.5M 5.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $459K $34K $380 $500
Cash & Short-Term Investments $459K $34K $380 $500
Total Current Assets $619K $46K $380 $500
Total Non-Current Assets $0 $194K $0 $0
Total Assets $619K $239K $380 $500
Accounts Payable $1.51M $1.36M -- --
Total Current Liabilities $2.11M $4.34M $113K $28K
Total Non-Current Liabilities $0 $0 $0 $0
Total Liabilities $2.11M $4.34M $113K $28K
Common Stock $866 $325 $500 $500
Retained Earnings -$9.29M -$4.12M -$113K -$28K
Total Stockholders' Equity -$1.49M -$4.10M -$978K -$27K
Total Equity -$1.49M -$4.10M -$978K -$27K

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $430K $670K $301K $459K $579K $1.35M $2.37M $34K
Cash & Short-Term Investments $430K $670K $301K $459K $579K $1.35M $2.37M $34K
Total Current Assets $1.09M $981K $706K $619K $979K $1.66M $2.85M $46K
Total Non-Current Assets $0 $0 $0 $0 $0 $0 $0 $194K
Total Assets $1.09M $981K $706K $619K $979K $1.66M $2.85M $239K
Accounts Payable $1.69M $1.67M $1.37M $1.51M $1.34M $667K $327K $1.36M
Total Current Liabilities $2.76M $2.65M $2.48M $2.11M $1.86M $1.19M $1.11M $4.34M
Total Non-Current Liabilities $0 $0 $0 $0 $0 $0 $0 $0
Total Liabilities $2.76M $2.65M $2.48M $2.11M $1.86M $1.19M $1.11M $4.34M
Common Stock $926 $905 $879 $866 $846 $846 $840 $325
Retained Earnings -$12.60M -$11.64M -$10.44M -$9.29M -$7.92M -$6.25M -$4.73M -$4.12M
Total Stockholders' Equity -$1.67M -$1.67M -$1.78M -$1.49M -$881K $474K $1.75M -$4.10M
Total Equity -$1.67M -$1.67M -$1.78M -$1.49M -$881K $474K $1.75M -$4.10M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$5.17M -$3.12M -$86K
Stock-Based Compensation $497K -- --
Change in Payables $497K $1.08M --
Operating Cash Flow -$4.78M -$649K -$81K
Financing Cash Flow $5.20M $679K $81K
Net Change in Cash $425K $29K -$120

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$957K -$1.21M -$1.15M -$1.37M -$1.68M -$1.52M -$603K -$857K
Stock-Based Compensation $184K $194K $345K -- $320K -- -- --
Change in Payables $42K $260K -$141K $174K $672K $340K -$688K $430K
Operating Cash Flow -$965K -$450K -$596K -$703K -$772K -$1.02M -$2.28M $113K
Common Stock Issued $0 $260K $652K -- -- -- -- --
Financing Cash Flow $724K $819K $438K $583K $0 $0 $4.62M -$194K
Net Change in Cash -$240K $369K -$158K -$120K -$772K -$1.02M $2.34M -$81K

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Return on Assets (ROA) -834.6% -1304.2% -22524.5%
Current Ratio 0.29x 0.01x 0.00x
Quick Ratio 0.22x 0.01x 0.00x

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -- -- -- -- -- -861.8% -194.0% --
Return on Assets (ROA) -430.0% -549.7% -808.7% -834.6% -475.4% -245.9% -118.6% -1304.2%
Current Ratio 0.39x 0.37x 0.28x 0.29x 0.53x 1.40x 2.57x 0.01x
Quick Ratio 0.16x 0.25x 0.12x 0.22x 0.31x 1.14x 2.14x 0.01x
Operating Cash Flow Growth (YoY) -- -- -- -723.9% -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001938571) · from June 30, 2022 Data through September 30, 2026 · synced Nov 20, 2026, 05:52 UTC · Open in terminal